Abstract
The addition of low-dose vasopressin to the treatment of septic shock does not reduce mortality compared to the use of norepinephrine alone, but allows a rapid reduction in norepinephrine requirements.Level of evidence: 1+ (RCT with a very low risk of bias)
| Original language | English |
|---|---|
| Pages (from-to) | 262-263 |
| Number of pages | 2 |
| Journal | Journal of the Intensive Care Society |
| Volume | 9 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2008 |